Sarepta Therapeutics Stock Forecast

Sell candidate since Jul 14, 2026 Loss -4.06%

The Sarepta Therapeutics stock price fell by -2.16% on the last day (Thursday, 16th Jul 2026) from $17.61 to $17.23. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.46% from a day low at $17.22 to a day high of $17.82. The price has fallen in 6 of the last 10 days and is down by -5.33% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -282 thousand shares and in total, 3 million shares were bought and sold for approximately $54.71 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.08% during the next 3 months and, with a 90% probability hold a price between $11.59 and $17.18 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SRPT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sarepta Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $18.76 and $17.27. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -16.03%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Monday, June 29, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Sarepta Therapeutics stock

Sarepta Therapeutics finds support from accumulated volume at $17.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.595 between high and low, or 3.46%. For the last week, the stock has had daily average volatility of 5.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SRPT) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Sarepta Therapeutics to open at $17.42, and during the day (based on 14 day Average True Range), to move between $16.74 and $17.72, which gives a possible trading interval of +/-$0.98 (+/-5.86%) up or down from last closing price. If Sarepta Therapeutics takes out the full calculated possible swing range there will be an estimated 5.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $17.02 (1.22%) than the resistance at $17.61 (2.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sarepta Therapeutics stock A Buy?

Sarepta Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.910 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $17.42 ( 1.11%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk